0001179110-21-010209.txt : 20211117 0001179110-21-010209.hdr.sgml : 20211117 20211117160432 ACCESSION NUMBER: 0001179110-21-010209 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211117 DATE AS OF CHANGE: 20211117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hewes L. Becker CENTRAL INDEX KEY: 0001840110 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 211420615 MAIL ADDRESS: STREET 1: C/O BLUEPRINT MEDICINES STREET 2: CORPORATION CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2021-11-15 0 0001597264 Blueprint Medicines Corp BPMC 0001840110 Hewes L. Becker C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer Common Stock 2021-11-15 4 M 0 729 66.24 A 26916 D Common Stock 2021-11-15 4 S 0 729 115.49 D 26187 D Stock Option (Right to Buy) 66.24 2021-11-15 4 M 0 729 0 D 2030-06-01 Common Stock 729 24792 D Effected pursuant to a trading plan adopted on August 13, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This option was granted on June 1, 2020. This option vested with respect to 25% of the shares underlying the option on June 1, 2021 and as to an additional 1/48th of the shares underlying the option each month thereafter. /s/ Ariel Hurley, Attorney-in-Fact 2021-11-17